Analysis and Commentary STEVEN GROSSMAN 2/6/15 Analysis and Commentary STEVEN GROSSMAN 2/6/15 POTUS's FY 16 Budget Request ... On Careful Reflection Read More Advocacy at a Glance STEVEN GROSSMAN 2/6/15 Advocacy at a Glance STEVEN GROSSMAN 2/6/15 FDA/Medical Innovation Policy Development Efforts Multiple and more Read More Uncategorized STEVEN GROSSMAN 2/2/15 Uncategorized STEVEN GROSSMAN 2/2/15 Alliance Welcomes President's Request for FDA Read More Analysis and Commentary STEVEN GROSSMAN 1/30/15 Analysis and Commentary STEVEN GROSSMAN 1/30/15 Parsing the President's Budget: Learnings to Date Read More Advocacy at a Glance STEVEN GROSSMAN 1/30/15 Advocacy at a Glance STEVEN GROSSMAN 1/30/15 Please Use Caution in Evaluating the Administration’s Initial FDA Numbers and more Read More Analysis and Commentary STEVEN GROSSMAN 1/23/15 Analysis and Commentary STEVEN GROSSMAN 1/23/15 Impact of Precision Medicine Initiative on FDA Read More Advocacy at a Glance STEVEN GROSSMAN 1/23/15 Advocacy at a Glance STEVEN GROSSMAN 1/23/15 State of the Union Includes Precision Medicine Initiative and more Read More Analysis and Commentary STEVEN GROSSMAN 1/16/15 Analysis and Commentary STEVEN GROSSMAN 1/16/15 The BCA and the FY 16 Budget "Squeeze" Read More Advocacy at a Glance STEVEN GROSSMAN 1/16/15 Advocacy at a Glance STEVEN GROSSMAN 1/16/15 Proponents of Increasing Non-Defense Appropriations Spending to be Active Again and more Read More Analysis and Commentary STEVEN GROSSMAN 1/10/15 Analysis and Commentary STEVEN GROSSMAN 1/10/15 Predictability and uncertainty in 2015 Read More Advocacy at a Glance STEVEN GROSSMAN 1/10/15 Advocacy at a Glance STEVEN GROSSMAN 1/10/15 Food Safety Regulatory Agenda for 2015 and more Read More Analysis and Commentary STEVEN GROSSMAN 12/19/14 Analysis and Commentary STEVEN GROSSMAN 12/19/14 FY 2016: Out with the Old; In with the New Read More Advocacy at a Glance STEVEN GROSSMAN 12/19/14 Advocacy at a Glance STEVEN GROSSMAN 12/19/14 FY 15 Appropriations Completed and more Read More Uncategorized STEVEN GROSSMAN 12/12/14 Uncategorized STEVEN GROSSMAN 12/12/14 The “Consolidated and Further Continuing Appropriations Act, 2015” Read More Analysis and Commentary STEVEN GROSSMAN 12/5/14 Analysis and Commentary STEVEN GROSSMAN 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More Advocacy at a Glance STEVEN GROSSMAN 12/5/14 Advocacy at a Glance STEVEN GROSSMAN 12/5/14 Appropriations Funding Deal Nearly in Place and more Read More Analysis and Commentary STEVEN GROSSMAN 11/20/14 Analysis and Commentary STEVEN GROSSMAN 11/20/14 "Turkey Day" ... and an Expression of Gratitude Read More Advocacy at a Glance STEVEN GROSSMAN 11/21/14 Advocacy at a Glance STEVEN GROSSMAN 11/21/14 Fate of FY 15 Appropriations Still Unresolved and more Read More Analysis and Commentary STEVEN GROSSMAN 11/14/14 Analysis and Commentary STEVEN GROSSMAN 11/14/14 "Fiscal Cliffs" and Life in "Interesting Times" Read More Advocacy at a Glance STEVEN GROSSMAN 11/14/14 Advocacy at a Glance STEVEN GROSSMAN 11/14/14 Lawmakers Return to Washington as Lame-Duck Session Begins and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 2/6/15 Analysis and Commentary STEVEN GROSSMAN 2/6/15 POTUS's FY 16 Budget Request ... On Careful Reflection Read More
Advocacy at a Glance STEVEN GROSSMAN 2/6/15 Advocacy at a Glance STEVEN GROSSMAN 2/6/15 FDA/Medical Innovation Policy Development Efforts Multiple and more Read More
Uncategorized STEVEN GROSSMAN 2/2/15 Uncategorized STEVEN GROSSMAN 2/2/15 Alliance Welcomes President's Request for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 1/30/15 Analysis and Commentary STEVEN GROSSMAN 1/30/15 Parsing the President's Budget: Learnings to Date Read More
Advocacy at a Glance STEVEN GROSSMAN 1/30/15 Advocacy at a Glance STEVEN GROSSMAN 1/30/15 Please Use Caution in Evaluating the Administration’s Initial FDA Numbers and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/23/15 Analysis and Commentary STEVEN GROSSMAN 1/23/15 Impact of Precision Medicine Initiative on FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 1/23/15 Advocacy at a Glance STEVEN GROSSMAN 1/23/15 State of the Union Includes Precision Medicine Initiative and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/16/15 Analysis and Commentary STEVEN GROSSMAN 1/16/15 The BCA and the FY 16 Budget "Squeeze" Read More
Advocacy at a Glance STEVEN GROSSMAN 1/16/15 Advocacy at a Glance STEVEN GROSSMAN 1/16/15 Proponents of Increasing Non-Defense Appropriations Spending to be Active Again and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/10/15 Analysis and Commentary STEVEN GROSSMAN 1/10/15 Predictability and uncertainty in 2015 Read More
Advocacy at a Glance STEVEN GROSSMAN 1/10/15 Advocacy at a Glance STEVEN GROSSMAN 1/10/15 Food Safety Regulatory Agenda for 2015 and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/19/14 Analysis and Commentary STEVEN GROSSMAN 12/19/14 FY 2016: Out with the Old; In with the New Read More
Advocacy at a Glance STEVEN GROSSMAN 12/19/14 Advocacy at a Glance STEVEN GROSSMAN 12/19/14 FY 15 Appropriations Completed and more Read More
Uncategorized STEVEN GROSSMAN 12/12/14 Uncategorized STEVEN GROSSMAN 12/12/14 The “Consolidated and Further Continuing Appropriations Act, 2015” Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/14 Analysis and Commentary STEVEN GROSSMAN 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 12/5/14 Advocacy at a Glance STEVEN GROSSMAN 12/5/14 Appropriations Funding Deal Nearly in Place and more Read More
Analysis and Commentary STEVEN GROSSMAN 11/20/14 Analysis and Commentary STEVEN GROSSMAN 11/20/14 "Turkey Day" ... and an Expression of Gratitude Read More
Advocacy at a Glance STEVEN GROSSMAN 11/21/14 Advocacy at a Glance STEVEN GROSSMAN 11/21/14 Fate of FY 15 Appropriations Still Unresolved and more Read More
Analysis and Commentary STEVEN GROSSMAN 11/14/14 Analysis and Commentary STEVEN GROSSMAN 11/14/14 "Fiscal Cliffs" and Life in "Interesting Times" Read More
Advocacy at a Glance STEVEN GROSSMAN 11/14/14 Advocacy at a Glance STEVEN GROSSMAN 11/14/14 Lawmakers Return to Washington as Lame-Duck Session Begins and more Read More
